The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to an infection or to a vaccine. This represents the first test licence signed by @MedsPatentPool & included in WHO’s #COVID19 Technology Access Pool
👉https://t.co/0EwiiWiAw8 pic.twitter.com/On0zNfLmTn— World Health Organization (WHO) (@WHO) November 23, 2021
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)